L
LEXICON PHARMACEUTICALS INC
NASDAQ: LXRX (Lexicon Pharmaceuticals, Inc.)
最近更新时间: 1小时之前2.02
-0.13 (-6.05%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Lexicon Pharmaceuticals, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-1.3
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -1.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -1.33 |
|
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 1.17% |
| 机构持股比例 | 74.93% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Artal Group S.A. | 30 Jun 2026 | 175,156,062 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合